Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies
ACS Omega · 25.02.2025 · 10 (7) · 6801-6813
DOI: 10.1021/acsomega.4c08885 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 14.02.2025. Verfasst von Ulviye Acar Çevik und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ankara Universitesi, Bilim Akademisi.
Abstract (Originalsprache)
The aim of this research is the synthesis of benzimidazole-1,3,4-oxadiazole derivatives that could be potential anticancer leads inhibiting VEGFR2. The compounds were evaluated for their cytotoxicity against cancer cell lines PANC-1, MCF-7, and A549 using the MTT assay. Two different normal cell lines (hTERT-HPNE and CCD-19Lu) were used to calculate the selectivity indices of the compounds. Compound 4r showed the highest anticancer activities, with IC50 = 5.5, 0.3, and 0.5 μM against the PANC-1, A549, and MCF-7 cell lines, respectively. Also, compounds 4r and 4s were further evaluated for their inhibitory activity against VEGFR2. VGFRA immunolocalizations of compounds 4r and 4s were visualized by the VEGFA immunofluorescent staining method. Molecular docking studies have proven that, as in sorafenib, compounds 4r and 4s show hydrogen bond formation with Asp1046 and Cys919 and hydrophobic interactions with other active site amino acids. Molecular dynamics simulations were carried out for compounds 4r and 4s to examine the stability and behavior of the protein–ligand complex obtained from molecular docking under in silico physiological conditions. An in silico ADME investigation was undertaken to confirm the druglikeness of the synthesized compounds. Furthermore, the stable geometries of the ligands were determined through the application of density functional theory (DFT). The optimized geometries were confirmed to correspond to true minima, as no imaginary frequencies were observed in the vibration frequency survey. The rotations of the thio and benzimidazole groups with respect to the 1,3,4-oxadiazole rings are 180 deg, and the molecules are planar.
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Erciyes University, Kayseri 38039, Turkey.
- Medicinal Plant, Drug and Scientific Research and Application Center (AUBIBAM), Anadolu University, Eskişehir 26470, Turkey.
- Department of Histology and Embryology, Sivas Cumhuriyet University, Sivas 58140, Turkey.
- Department of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas 58140, Turkey.
- Department of Physics, Faculty of Arts and Science, Hitit University, Çorum 19030, Turkey.
ORCID-Profile: Ulviye Acar Çevik, Ismail Celik, Hayrani Eren Bostancı
Förderung
- Ankara Universitesi
- Bilim Akademisi
Zitieren
APA
Çevik, U. A., Celik, I., Görgülü, Ş., Şahin İnan, Z. D., Bostancı, H. E., Karayel, A., Özkay, Y., & Kaplancıklı, Z. A. (2025). Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies. ACS Omega, 10(7), 6801-6813. https://doi.org/10.1021/acsomega.4c08885
Vancouver
Çevik UA, Celik I, Görgülü Ş, Şahin İnan ZD, Bostancı HE, Karayel A, et al. Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies. ACS Omega. 2025;10(7):6801-6813. doi:10.1021/acsomega.4c08885
BibTeX
@article{evik2025,
author = {Çevik, Ulviye Acar and Celik, Ismail and Görgülü, Şennur and Şahin İnan, Zeynep Deniz and Bostancı, Hayrani Eren and Karayel, Arzu and Özkay, Yusuf and Kaplancıklı, Zafer Asım},
title = {Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies},
journal = {ACS Omega},
year = {2025},
volume = {10},
number = {7},
pages = {6801--6813},
doi = {10.1021/acsomega.4c08885}
}
EUVIMED